- Home
- LNKB vs SMTI Comparison
LNKB vs SMTI Comparison
Compare LNKB & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNKB
- SMTI
- Stock Information
- Founded
- LNKB 2018
- SMTI 1982
- Country
- LNKB United States
- SMTI United States
- Employees
- LNKB N/A
- SMTI N/A
- Industry
- LNKB
- SMTI Medical/Dental Instruments
- Sector
- LNKB
- SMTI Health Care
- Exchange
- LNKB Nasdaq
- SMTI Nasdaq
- Market Cap
- LNKB 256.4M
- SMTI 252.1M
- IPO Year
- LNKB N/A
- SMTI N/A
- Fundamental
- Price
- LNKB $7.67
- SMTI $29.65
- Analyst Decision
- LNKB Strong Buy
- SMTI Strong Buy
- Analyst Count
- LNKB 1
- SMTI 2
- Target Price
- LNKB $9.00
- SMTI $49.50
- AVG Volume (30 Days)
- LNKB 67.6K
- SMTI 45.1K
- Earning Date
- LNKB 07-28-2025
- SMTI 08-11-2025
- Dividend Yield
- LNKB 3.91%
- SMTI N/A
- EPS Growth
- LNKB N/A
- SMTI N/A
- EPS
- LNKB 0.97
- SMTI N/A
- Revenue
- LNKB $120,786,000.00
- SMTI $91,569,883.00
- Revenue This Year
- LNKB $21.23
- SMTI $23.53
- Revenue Next Year
- LNKB N/A
- SMTI $5.93
- P/E Ratio
- LNKB $7.93
- SMTI N/A
- Revenue Growth
- LNKB 135.60
- SMTI 34.65
- 52 Week Low
- LNKB $6.00
- SMTI $25.86
- 52 Week High
- LNKB $7.98
- SMTI $39.08
- Technical
- Relative Strength Index (RSI)
- LNKB 66.63
- SMTI 54.56
- Support Level
- LNKB $6.67
- SMTI $28.00
- Resistance Level
- LNKB $7.70
- SMTI $30.59
- Average True Range (ATR)
- LNKB 0.25
- SMTI 1.22
- MACD
- LNKB 0.08
- SMTI 0.27
- Stochastic Oscillator
- LNKB 96.39
- SMTI 74.93
About LNKB LINKBANCORP Inc.
Linkbancorp Inc operates in the banking industry. It provides banking services for individuals and businesses such as commercial lending, non-profit banking, treasury management, deposits and loans. Company portfolio segments includes: Agriculture and farmland, Construction, Commercial & industrial, Commercial real estate, Residential real estate, Municipal, customers and Other loans.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.